Skip to main content
. 2020 Oct 22;20(6):240. doi: 10.3892/etm.2020.9370

Figure 3.

Figure 3

Inhibition of tumors in mice by paroxetine combined with fluorouracil. Ki-67 was examined by immunohistochemistry in each group. (A) Representative images and (B) quantification of immunohistochemistry (scale bar, 50 µm). *P<0.05. CA, cancer model group; CD, cancer depression model group; CDP, cancer depression with paroxetine group; CDF, cancer depression with fluorouracil group; CDP+F, cancer depression with paroxetine and fluorouracil group.